Rapport Therapeutics, Inc. (RAPP) Reports Q1 Loss of $0.68
Tweet
Share
E-mailGet Alerts RAPP Hot Sheet
Join SI Premium – FREE
Rapport Therapeutics, Inc. (NASDAQ: RAPP) reported Q1 EPS of ($0.68).
For earnings history and earnings-related data on Rapport Therapeutics, Inc. (RAPP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- HSBC Downgrades China Power International (2380:HK) (CPWIF) to Hold
- UBS Downgrades Converge ICT Solutions Inc (CNVRG:PM) to Neutral
- UBS Downgrades Klarna (KLAR) to Neutral
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
